GlassScriptPhysician profile
Mark F Sullivan
NPI 1497722615
$1,386.64
in general payments reported to CMS, 2019-2025
14 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.85 · 2020: $84.46 · 2021: $257 · 2022: $59.04 · 2023: $384 · 2024: $118 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670 · Travel and Lodging: $208 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.30 |
| Travel and Lodging | $207.90 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $361.11 | 2020-2025 | Konect Resilia, Edwards Intuity Elite Valve System |
| Olympus Corporation of The Americas | $262.90 | 2023 | Single Use Suction Valve (Sterile), Single Use Electrosurgical Hemostatic Forceps, Single Use Electrosurgical Knife Kd-655 |
| E.R. Squibb & Sons, L.L.C. | $135.72 | 2024-2025 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $114.85 | 2021-2025 | Onglyza |
| Atricure, INC. | $82.94 | 2020-2021 | |
| Intuitive Surgical, INC. | $82.77 | 2021 | |
| Covidien LP | $67.53 | 2019 | |
| Merck Sharp & Dohme LLC | $64.36 | 2023-2025 | Keytruda |
| Amgen INC. | $51.62 | 2023 | Repatha |
| Davol INC. | $49.23 | 2020-2025 | Progel Applicator Spray Tips |
| Vanda Pharmaceuticals INC. | $44.52 | 2021 | |
| Abbott Laboratories | $26.59 | 2021 | |
| Pinnacle Biologics, INC | $22.18 | 2021 | |
| Medtronic Vascular, INC. | $20.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.